Arcellx Shares Rise After Canaccord Genuity Initiation
12:47PM ET 7/20/2022 MT NewswiresArcellx (ACLX) shares rose about 9% in Wednesday afternoon trading after Canaccord Genuity initiated the stock at buy and set the price target of $32. ...
Quotes Snapshot > ACLX
Arcellx Inc ACLX:NASDAQ
Last Price$18.55NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22
NASDAQ 15-minute delayed Bid/Ask Quotes
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$15.62 (1)
Ask (Size)$18.54 (5)
Day Low / HighN/A - N/A
Volume230.9 K
Read more news Recent News
--Canaccord Genuity Starts Arcellx at Buy With $32 Price Target
5:36AM ET 7/20/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
--SVB Securities Adjusts Arcellx Price Target to $38 From $47, Maintains Outperform Rating
1:25PM ET 6/23/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Arcellx Closes Upsized Common Stock Offering
4:12PM ET 6/21/2022 MT NewswiresArcellx (ACLX) said late Tuesday it has closed the upsized public offering of 8.05 million shares of common stock at $16 per share for gross proceeds of...
View all Commentary and Analysis
ASCO Annual Meeting 2022: An Innovation Showcase In Cancer Treatment
5:30AM ET 6/24/2022 Seeking AlphaArcellx: Speculative Buy For Their 'Best-In-Class' CAR-T Cell Therapy
10:58AM ET 6/08/2022 Seeking AlphaArcellx (ACLX) Investor Presentation - Slideshow
3:25PM ET 5/17/2022 Seeking AlphaStocks To Watch: Spotlight On Ukraine, FOMC Speakers, Target, Lucid And DraftKings
9:53AM ET 2/26/2022 Seeking AlphaCompany Profile
Business Description
| Number of Employees | N/A |
| Recent SEC Filing | 06/27/2022 SC 13D/A |
Company Highlights
| Price Open | $18.99 |
| Previous Close | $18.95 |
| 52 Week Range | $6.04 - 26.91 |
| Market Capitalization | $812.2 M |
| Shares Outstanding | 43.8 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 08/11/2022 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | N/A |
| Earnings per Share | -$2.07 |
| Beta vs. S&P 500 | N/A |
| Revenue | N/A |
| Net Profit Margin | N/A |
| Return on Equity | -76.49% |
Analyst Ratings as of 07/19/2022
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |